Fort LP’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,638
Closed -$896K 267
2022
Q1
$896K Sell
1,638
-748
-31% -$393K 0.34% 152
2021
Q4
$1.57M Sell
2,386
-458
-16% -$288K 0.51% 72
2021
Q3
$1.77M Sell
2,844
-612
-18% -$411K 0.59% 15
2021
Q2
$2.18M Sell
3,456
-467
-12% -$258K 0.63% 4
2021
Q1
$1.92M Buy
3,923
+175
+5% +$87.7K 0.54% 40
2020
Q4
$1.87M Buy
3,748
+1,329
+55% +$595K 0.56% 16
2020
Q3
$951K Buy
2,419
+1,423
+143% +$526K 0.4% 122
2020
Q2
$329K Sell
996
-198
-17% -$57.3K 0.18% 213
2020
Q1
$289K Buy
1,194
+828
+226% +$216K 0.06% 267
2019
Q4
$96K Buy
+366
New +$96.4K 0.02% 349

Other funds holding IDXX

Fort LP's IDXX Position: Q2 2022 in Review

Fort LP sold out of Idexx Laboratories (IDXX) in Q2 2022, closing a stake of 1,638 shares — an estimated $896K sold.

Fort LP first reported a position in IDXX in Q4 2019 and held it in 10 quarters. The position peaked at $2.18M in Q2 2021. 956 funds tracked by Wall St. Rank hold IDXX as of Q2 2022.

  • Fort LP reported no remaining Idexx Laboratories position as of Q2 2022 after selling out during the quarter.
  • Fort LP sold 1,638 Idexx Laboratories shares in Q2 2022, an estimated $896K.
  • Fort LP first reported a position in Idexx Laboratories in Q4 2019 and held it in 10 quarters.
  • Fort LP's Idexx Laboratories position peaked at $2.18M in Q2 2021.
  • 956 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2022.

Based on Fort LP's 13F filing for Q2 2022, filed 12 Aug 2022.